Résumé
Several step-based daily targets have been widely circulated, but there is a lack of empirical population-based evidence to support such guidance. We examined dose-response associations between step count and classical CVD risk markers (glycated hemoglobin, high density lipoprotein cholesterol, triglycerides, and C-reactive protein) in 4665 adults (aged 46 years; 51.4% female) in a cross-sectional study. Step counts were measured from a thigh mounted accelerometer (activPAL) worn over 7 days. The shape of the dose-response curve for most risk markers was “L-shaped,” with linear risk reduction up to around 10 000 steps a day. Controlling for stepping intensity did not materially alter our results.
Langue d'origine | English |
---|---|
Journal | Scandinavian Journal of Medicine and Science in Sports |
DOI | |
Statut de publication | Accepted/In press - 2022 |
Publié à l'externe | Oui |
Note bibliographique
Funding Information:British Heart Foundation grant (SP/F/20/150002)
Publisher Copyright:
© 2022 The Authors. Scandinavian Journal of Medicine & Science In Sports published by John Wiley & Sons Ltd.
ASJC Scopus Subject Areas
- Orthopedics and Sports Medicine
- Physical Therapy, Sports Therapy and Rehabilitation
PubMed: MeSH publication types
- Journal Article